Advertisement
ASTH vs NIVF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Buy and NIVF is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 1 FA rating(s) are green whileNIVF’s FA Score has 2 green FA rating(s).
- ASTH’s FA Score: 1 green, 4 red.
- NIVF’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 5 TA indicator(s) are bullish while NIVF’s TA Score has 5 bullish TA indicator(s).
- ASTH’s TA Score: 5 bullish, 3 bearish.
- NIVF’s TA Score: 5 bullish, 3 bearish.
Price Growth
ASTH (@Hospital/Nursing Management) experienced а +10.95% price change this week, while NIVF (@Hospital/Nursing Management) price change was -10.00% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.69%. For the same industry, the average monthly price growth was +3.32%, and the average quarterly price growth was +4.03%.
Reported Earning Dates
ASTH is expected to report earnings on Feb 19, 2026.
Industries' Descriptions
@Hospital/Nursing Management (-0.69% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ASTH | NIVF | ASTH / NIVF | |
| Capitalization | 1.26B | 1.07M | 117,978% |
| EBITDA | 108M | 17.5M | 617% |
| Gain YTD | -20.330 | -99.960 | 20% |
| P/E Ratio | 132.21 | 0.00 | 13,116,124% |
| Revenue | 2.9B | 4.58M | 63,301% |
| Total Cash | 463M | 295K | 156,949% |
| Total Debt | 1.09B | 5.5M | 19,749% |
ASTH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 21 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | |
PROFIT vs RISK RATING 1..100 | 93 | |
SMR RATING 1..100 | 89 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 3 | |
SEASONALITY SCORE 1..100 | 17 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ASTH | NIVF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 86% | 4 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| Advances ODDS (%) | 2 days ago 79% | 17 days ago 89% |
| Declines ODDS (%) | 16 days ago 73% | 2 days ago 90% |
| BollingerBands ODDS (%) | N/A | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 90% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GCEDX | 11.26 | 0.03 | +0.27% |
| Goldman Sachs Clean Energy Income Ins | |||
| TGADX | 28.56 | 0.06 | +0.21% |
| Templeton Growth Adv | |||
| GGESX | 24.93 | 0.05 | +0.20% |
| Nationwide Schroders Global Eq Instl Svc | |||
| MCSPX | 11.63 | 0.02 | +0.17% |
| BlackRock Advantage SMID Cap Inv C | |||
| FCCVX | 39.71 | N/A | N/A |
| Fidelity Advisor Convertible Secs C | |||
ASTH and
Correlation & Price change
A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.
| Ticker / NAME | Correlation To ASTH | 1D Price Change % | ||
|---|---|---|---|---|
| ASTH | 100% | +2.78% | ||
| ACHC - ASTH | 48% Loosely correlated | +1.42% | ||
| DCGO - ASTH | 39% Loosely correlated | +4.04% | ||
| PNTG - ASTH | 31% Poorly correlated | -0.44% | ||
| UHS - ASTH | 31% Poorly correlated | -0.08% | ||
| HCA - ASTH | 30% Poorly correlated | +0.00% | ||
More | ||||
NIVF and
Correlation & Price change
A.I.dvisor tells us that NIVF and AUNA have been poorly correlated (+15% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NIVF and AUNA's prices will move in lockstep.
| Ticker / NAME | Correlation To NIVF | 1D Price Change % | ||
|---|---|---|---|---|
| NIVF | 100% | -0.97% | ||
| AUNA - NIVF | 15% Poorly correlated | +0.87% | ||
| ASTH - NIVF | 8% Poorly correlated | +2.78% | ||
| BTMD - NIVF | 7% Poorly correlated | +5.32% | ||
| NAKA - NIVF | 6% Poorly correlated | -1.69% | ||
| EHAB - NIVF | 5% Poorly correlated | +1.07% | ||
More | ||||